Ultrasound Assessment of Residual Gastric Content in Critically Ill Patients

This prospective observational study aims to assess whether ultrasound assessment of gastric content may be useful for the monitoring of the gastric residual content in critically ill patients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critically Ill Patients

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Nord, Marseille, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Critically ill patients under mechanical ventilation and enteral feeding through a gastric tube since >48 h

Exclusion criteria

Digestive hemorrhage Contra-indication to prokinetic drugs Enteral feeding through jejunostomy or gastrostomy Pregnancy

Treatment and study plan

Ultrasound examination of the antrum

Diagnostic Test

Ultrasound assessment of gastric content will be performed : prior to suction of gastric content through a gastric tube (method to assess the residual gastric content volume), after this suctioning of gastric content, then after reinjection of the content suctioned into the stomach (max 250 ml) and 1h30 later

Primary outcomes

change in antral cross sectional area measured by ultrasonography after suctioning gastric volume

Time frame: prior to and immediately after suctioning of gastric content volume through a gastric tube

Ultrasound measurement of antral area and qualitative assessment
Change in antral area after administration of prokinetic drug

Time frame: Ultrasound assessment of gastric content after reinjection of suctioned gastric content and 1h30 later (1 h after the end of the infusion of prokinetic drug)

If aspirated gastric content volume was > 250 ml, only 250 ml will be reinjected into the stomach and a prokientic drug will be administered (current protocol in our units). Antral area will be measured prior to and 90 min after the start of the infusion

Sponsors and collaborators

Lead sponsor

Hôpital Edouard Herriot

Other

Registry information

Acronym: GastrICU

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Jul 2, 2017
Registry last updated: May 7, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed